Reference Group Choice and Antibiotic Resistance Outcomes

Kaye, Keith S.; Engemann, John J.; Mozaffari, Essy; Carmeli, Yehuda

Back to Previous Page

Reference Group Choice and Antibiotic Resistance Outcomes

Published Date:

Jun 2004

Source:

Emerg Infect Dis. 10(6):1125-1128.

[PDF-71.45 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Kaye, Keith S. ; Engemann, John J. ; Mozaffari, Essy ; Carmeli, Yehuda ;

Description:

Two types of cohort studies examining patients infected with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) were contrasted, using different reference groups. Cases were compared to uninfected patients and patients infected with the corresponding, susceptible organism. VRE and MRSA were associated with adverse outcomes. The effect was greater when uninfected control patients were used.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

File Type:

Supporting Files:

	02-0665.nxml	text/plain
	license.txt	text/plain

No Related Documents.

Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005

[PDF - 131.24 KB]

Personal Author:

Zilberberg, Marya D. ; Shorr, Andrew F. ; ...

Published Date:

Nov 2008

Source:

Emerg Infect Dis. 14(11):1756-1758

Description:

From 2000 through 2005, hospitalizations with resistant infections (methicillin-resistant Staphylococcus aureus, Clostridium difficile-associated dise...

File Type:

[PDF - 131.24 KB]

File Type:

[PDF - 131.24 KB]
Investigation and control of Vancomycin-resistant Staphylococcus aureus (VRSA): 2015 update

[PDF - 281.28 KB]

Personal Author:

Walters, Maroya ; Lonsway, David ; ...

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion.

Published Date:

April 2015

Description:

Updated: April 2015This document is a guide to conducting a public health investigation of patients from whom vancomycin-resistant Staphylococcus aure...

File Type:

[PDF - 281.28 KB]

File Type:

[PDF - 281.28 KB]
Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery.

[PDF - 75.90 KB]

Personal Author:

Zanetti, G. ; Goldie, S. J. ; ...

Published Date:

2001 Sep-Oct

Source:

Emerg Infect Dis. 7(5):820-827.

Description:

Routine us of vancomycin for perioperative prophylaxis is discouraged, principally to minimize microbial resistance to it. However, outcomes and costs...

File Type:

[PDF - 75.90 KB]

File Type:

[PDF - 75.90 KB]
Clinical Significance of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia1

[PDF - 345.00 KB]

Personal Author:

Schwaber, Mitchell J. ; Wright, Sharon B. ; ...

Published Date:

Jun 2003

Source:

Emerg Infect Dis. 9(6):657-664.

Description:

We conducted a retrospective study of the clinical aspects of bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) with heterogeneo...

File Type:

[PDF - 345.00 KB]

File Type:

[PDF - 345.00 KB]
Methicillin-resistant Staphylococcus aureus in Taiwan

[PDF - 143.09 KB]

Personal Author:

Chen, Feng-Jui ; Lauderdale, Tsai-Ling ; ...

Published Date:

Nov 2005

Source:

Emerg Infect Dis. 11(11):1761-1763.

Description:

We found a virulent closely related clone (Panton-Valentine leukocidin-positive, SCCmec V:ST59) of methicillin-resistant Staphylococcus aureus in inpa...

File Type:

[PDF - 143.09 KB]

File Type:

[PDF - 143.09 KB]

Reference Group Choice and Antibiotic Resistance Outcomes

Reference Group Choice and Antibiotic Resistance Outcomes

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC